News | ECMO Systems | February 22, 2018

New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

ECMO-based protocol improves sudden cardiac arrest survival from 0 to 40 percent

New Protocol Gives Patients Fighting Chance to Survive Cardiac Arrest

February 22, 2018 — When someone goes into cardiac arrest and first responders cannot shock their heart back into rhythm, there is virtually no chance of survival. However, a new protocol being tested at The Ohio State University Wexner Medical Center is already saving lives – increasing survival rates from zero to about 40 percent.

“It’s astounding that patients are able to fully recover and walk out of the hospital when they would have been pronounced dead in the field before this protocol was in place,” said K. Dean Boudoulas, M.D., a cardiologist and assistant professor of internal medicine at The Ohio State University Wexner Medical Center.

The extracorporeal cardiopulmonary resuscitation (ECPR) protocol was developed through a partnership with the Columbus Division of Fire. It is initiated by EMS if they are not able to restore normal rhythm after shocking a patient’s heart three times. After alerting the hospital, emergency personnel connect the patient to a device that automatically delivers CPR to preserve the patient’s brain and organ function on the way to the hospital. Upon arrival, the patient bypasses the emergency room and is taken straight to the heart catheterization lab where they are connected to an extracorporeal membrane oxygenation (ECMO) machine.

“This allows the heart and lungs to rest while doctors perform a heart catheterization to find the problem, which is usually a blocked artery,” said Bryan Whitson, M.D., Ph.D., director of the Collaboration for Organ Perfusion, Protection, Engineering and Regeneration at Ohio State.

With positive results from this and other pilot studies, experts hope that the protocol will become standard care in treating cardiac arrests.

Watch the VIDEO: Ohio State University Introduces ECMO Protocol for Cardiac Arrest

For more information: www.wexnermedical.osu.edu

 


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now